Marshall Fordyce

PRESIDENT AND CEO

Marshall Fordyce (PRESIDENT AND CEO) filed 10 Form 4 reports in the trailing twelve months (0 purchases, 10 sales, 3 filed past the two-business-day deadline), most often in Vera Therapeutics, Inc. (VERA). The largest single filing was $1.8M of VERA (43,050 sh across 2 lots, as filed), executed Jul 7.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 10 sells · 3 late

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$9.4M

shares × price, as filed

Last traded

Sep 15

Filed Sep 17

Median ADV $64.6M across their filed names

Open performance→

Volume by month

Buys $0 Sells $14.9M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 10 filings

Sector per market data · by filing · past 12 months

Most traded names

VERA Vera Therapeutics, Inc. VERA · 0 buys · 19 sells 19 filings

Recent filings

VERASALE Vera Therapeutics, Inc. View filing → $684K
18,500 sh × $37.00
Exec Sep 15
Filed Sep 17 · 4:28 PM ET VERASALE Vera Therapeutics, Inc. View filing → $650K
18,500 sh × $35.12
Exec Sep 2
Filed Sep 4 · 4:15 PM ET VERASALE Vera Therapeutics, Inc. View filing → $1.8M
43,050 sh across 2 lots
Exec Jul 7
Filed Aug 12 · 6:42 PM ET † VERASALE Vera Therapeutics, Inc. View filing → $1.8M
43,050 sh across 2 lots
Exec Jul 7
Filed Jul 9 · 4:45 PM ET VERASALE Vera Therapeutics, Inc. View filing → $698K
18,412 sh × $37.93
Exec Jun 23
Filed Aug 12 · 6:41 PM ET † VERASALE Vera Therapeutics, Inc. View filing → $698K
18,412 sh × $37.93
Exec Jun 23
Filed Jun 24 · 5:30 PM ET VERASALE Vera Therapeutics, Inc. View filing → $680K
18,500 sh across 2 lots
Exec May 12
Filed Aug 12 · 6:39 PM ET † VERASALE Vera Therapeutics, Inc. View filing → $680K
18,500 sh across 2 lots
Exec May 12
Filed May 13 · 5:30 PM ET More filings →